159 related articles for article (PubMed ID: 20040039)
1. Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?
Douketis JD; Spyropoulos AC
J Thromb Haemost; 2010 Mar; 8(3):496-8. PubMed ID: 20040039
[No Abstract] [Full Text] [Related]
2. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
Steib A; Barre J; Mertes M; Morel MH; Nathan N; Ozier Y; Treger M; Samama CM
J Thromb Haemost; 2010 Mar; 8(3):499-503. PubMed ID: 19912513
[TBL] [Abstract][Full Text] [Related]
3. Perioperative management of antithrombotic therapy in cardiovascular patients.
Nuttall MT; Rodgers GM
Methodist Debakey Cardiovasc J; 2011; 7(4):10-4. PubMed ID: 22143470
[TBL] [Abstract][Full Text] [Related]
4. Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
Biedermann JS; Rademacher WMH; Hazendonk HCAM; van Diermen DE; Leebeek FWG; Rozema FR; Kruip MJHA
Thromb Haemost; 2017 Jun; 117(7):1432-1439. PubMed ID: 28405671
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor.
Odak S
J Orthop Trauma; 2009 Aug; 23(7):550; author reply 550. PubMed ID: 19633468
[No Abstract] [Full Text] [Related]
6. Perioperative management of patients with antiphospholipid syndrome: a single-center experience.
Atisha-Fregoso Y; Espejo-Poox E; Carrillo-Maravilla E; Pulido-Ramírez AL; Lugo Baruqui D; Hernández-Molina G; Cabral AR
Rheumatol Int; 2017 Jul; 37(7):1159-1164. PubMed ID: 28474094
[TBL] [Abstract][Full Text] [Related]
7. [Vitamin K antagonists: mechanism of anticoagulant action and laboratory control over therapy (a lecture)].
Lipatova NA; Titaeva EV; Dobrovol'skiĭ AB
Klin Lab Diagn; 2006 May; (5):25-32. PubMed ID: 16827235
[No Abstract] [Full Text] [Related]
8. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation.
Tripodi A; Moia M
J Thromb Haemost; 2012 Oct; 10(10):2207-8. PubMed ID: 22882756
[No Abstract] [Full Text] [Related]
9. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
[TBL] [Abstract][Full Text] [Related]
10. Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours.
Salaun A; de Maistre E; Daller M; Sombrun C; Chagué F; Bichat F; Rochette L; Danchin N; Fauchier L; Zeller M; Cottin Y
Arch Cardiovasc Dis; 2024 May; 117(5):351-357. PubMed ID: 38644068
[TBL] [Abstract][Full Text] [Related]
11. Perioperative management of vitamin K antagonists in patients with low thromboembolic risk undergoing elective surgery: A prospective experience.
Becerra AF; Cornavaca MT; Revigliono JI; Contreras A; Albertini R; Tabares AH
Med Clin (Barc); 2017 Oct; 149(7):281-286. PubMed ID: 28283268
[TBL] [Abstract][Full Text] [Related]
12. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
Angelo M; Stockner I; Wiedermann CJ
Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
[TBL] [Abstract][Full Text] [Related]
13. New oral anticoagulants versus vitamin K antagonists in countries with good INR control.
Coppens M
Neth J Med; 2013 May; 71(4):168-9. PubMed ID: 23723109
[No Abstract] [Full Text] [Related]
14. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation interruptus: not without risk.
Ezekowitz MD
Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
[No Abstract] [Full Text] [Related]
16. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of warfarin reversal in orthopedic trauma surgery patients.
Tharmarajah P; Pusey J; Keeling D; Willett K
J Orthop Trauma; 2007 Jan; 21(1):26-30. PubMed ID: 17211265
[TBL] [Abstract][Full Text] [Related]
18. To bridge or not to bridge: that is the question. The argument FOR bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures.
Spyropoulos AC
J Thromb Thrombolysis; 2010 Feb; 29(2):192-8. PubMed ID: 19882304
[No Abstract] [Full Text] [Related]
19. The effect of vitamin K supplementation on anticoagulant treatment.
Rombouts EK; Rosendaal FR; van der Meer FJ
J Thromb Haemost; 2006 Mar; 4(3):691-2. PubMed ID: 16460460
[No Abstract] [Full Text] [Related]
20. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
